309 related articles for article (PubMed ID: 17828757)
1. Heterogeneity of monoclonal antibodies.
Liu H; Gaza-Bulseco G; Faldu D; Chumsae C; Sun J
J Pharm Sci; 2008 Jul; 97(7):2426-47. PubMed ID: 17828757
[TBL] [Abstract][Full Text] [Related]
2. Method to convert N-terminal glutamine to pyroglutamate for characterization of recombinant monoclonal antibodies.
Xu W; Peng Y; Wang F; Paporello B; Richardson D; Liu H
Anal Biochem; 2013 May; 436(1):10-2. PubMed ID: 23357233
[TBL] [Abstract][Full Text] [Related]
3. Investigation of N-terminal glutamate cyclization of recombinant monoclonal antibody in formulation development.
Yu L; Vizel A; Huff MB; Young M; Remmele RL; He B
J Pharm Biomed Anal; 2006 Oct; 42(4):455-63. PubMed ID: 16828250
[TBL] [Abstract][Full Text] [Related]
4. Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass Spectrometry.
Yan Y; Wei H; Fu Y; Jusuf S; Zeng M; Ludwig R; Krystek SR; Chen G; Tao L; Das TK
Anal Chem; 2016 Feb; 88(4):2041-50. PubMed ID: 26824491
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo modifications of recombinant and human IgG antibodies.
Liu H; Ponniah G; Zhang HM; Nowak C; Neill A; Gonzalez-Lopez N; Patel R; Cheng G; Kita AZ; Andrien B
MAbs; 2014; 6(5):1145-54. PubMed ID: 25517300
[TBL] [Abstract][Full Text] [Related]
6. Understanding the conformational impact of chemical modifications on monoclonal antibodies with diverse sequence variation using hydrogen/deuterium exchange mass spectrometry and structural modeling.
Zhang A; Hu P; MacGregor P; Xue Y; Fan H; Suchecki P; Olszewski L; Liu A
Anal Chem; 2014 Apr; 86(7):3468-75. PubMed ID: 24597564
[TBL] [Abstract][Full Text] [Related]
7. Identification of deamidation and isomerization sites on pharmaceutical recombinant antibody using H(2)(18)O.
Terashima I; Koga A; Nagai H
Anal Biochem; 2007 Sep; 368(1):49-60. PubMed ID: 17617368
[TBL] [Abstract][Full Text] [Related]
8. Studies in serum support rapid formation of disulfide bond between unpaired cysteine residues in the VH domain of an immunoglobulin G1 molecule.
Ouellette D; Alessandri L; Chin A; Grinnell C; Tarcsa E; Radziejewski C; Correia I
Anal Biochem; 2010 Feb; 397(1):37-47. PubMed ID: 19766583
[TBL] [Abstract][Full Text] [Related]
9. Complementary MS methods assist conformational characterization of antibodies with altered S-S bonding networks.
Jones LM; Zhang H; Cui W; Kumar S; Sperry JB; Carroll JA; Gross ML
J Am Soc Mass Spectrom; 2013 Jun; 24(6):835-45. PubMed ID: 23483515
[TBL] [Abstract][Full Text] [Related]
10. Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody.
Liu H; Bulseco GG; Sun J
Immunol Lett; 2006 Aug; 106(2):144-53. PubMed ID: 16831470
[TBL] [Abstract][Full Text] [Related]
11. Modifications of recombinant monoclonal antibodies in vivo.
Liu H; Nowak C; Patel R
Biologicals; 2019 May; 59():1-5. PubMed ID: 30910309
[TBL] [Abstract][Full Text] [Related]
12. Characterization of trisulfide modification in antibodies.
Gu S; Wen D; Weinreb PH; Sun Y; Zhang L; Foley SF; Kshirsagar R; Evans D; Mi S; Meier W; Pepinsky RB
Anal Biochem; 2010 May; 400(1):89-98. PubMed ID: 20085742
[TBL] [Abstract][Full Text] [Related]
13. Assessment of disulfide and hinge modifications in monoclonal antibodies.
Moritz B; Stracke JO
Electrophoresis; 2017 Mar; 38(6):769-785. PubMed ID: 27982442
[TBL] [Abstract][Full Text] [Related]
14. Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometry.
Chevreux G; Tilly N; Bihoreau N
Anal Biochem; 2011 Aug; 415(2):212-4. PubMed ID: 21596014
[TBL] [Abstract][Full Text] [Related]
15. Determination of the origin of the N-terminal pyro-glutamate variation in monoclonal antibodies using model peptides.
Dick LW; Kim C; Qiu D; Cheng KC
Biotechnol Bioeng; 2007 Jun; 97(3):544-53. PubMed ID: 17099914
[TBL] [Abstract][Full Text] [Related]
16. Resolving disulfide structural isoforms of IgG2 monoclonal antibodies by ion mobility mass spectrometry.
Bagal D; Valliere-Douglass JF; Balland A; Schnier PD
Anal Chem; 2010 Aug; 82(16):6751-5. PubMed ID: 20704363
[TBL] [Abstract][Full Text] [Related]
17. Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function.
Liu H; May K
MAbs; 2012; 4(1):17-23. PubMed ID: 22327427
[TBL] [Abstract][Full Text] [Related]
18. The effect of cosolutes on the isomerization of aspartic acid residues and conformational stability in a monoclonal antibody.
Wakankar AA; Liu J; Vandervelde D; Wang YJ; Shire SJ; Borchardt RT
J Pharm Sci; 2007 Jul; 96(7):1708-18. PubMed ID: 17238195
[TBL] [Abstract][Full Text] [Related]
19. Microheterogeneity of Recombinant Antibodies: Analytics and Functional Impact.
Beyer B; Schuster M; Jungbauer A; Lingg N
Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 28862393
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of protein therapeutics to spontaneous chemical modifications by oxidation, cyclization, and elimination reactions.
Grassi L; Cabrele C
Amino Acids; 2019 Nov; 51(10-12):1409-1431. PubMed ID: 31576455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
